Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcesspositive regulation of serine-type peptidase activity

SEMG1 SEMG2

1.27e-053432GO:1902573
GeneOntologyBiologicalProcesspositive regulation of serine-type endopeptidase activity

SEMG1 SEMG2

1.27e-053432GO:1900005
GeneOntologyBiologicalProcessnegative regulation of cilium movement

SEMG1 SEMG2

2.54e-054432GO:0003354
GeneOntologyBiologicalProcessnegative regulation of flagellated sperm motility

SEMG1 SEMG2

2.54e-054432GO:1901318
GeneOntologyBiologicalProcessmating plug formation

SEMG1 SEMG2

2.54e-054432GO:0042628
GeneOntologyBiologicalProcessnegative regulation of cilium-dependent cell motility

SEMG1 SEMG2

2.54e-054432GO:1902020
GeneOntologyBiologicalProcessregulation of serine-type peptidase activity

SEMG1 SEMG2

1.89e-0410432GO:1902571
GeneOntologyBiologicalProcessregulation of serine-type endopeptidase activity

SEMG1 SEMG2

1.89e-0410432GO:1900003
DomainZnf_C2H2-like

ZNF597 TRERF1 ZMAT3 ZNF552 IKZF3 DZIP1 EEA1 GPATCH8 ZIM3 ZNF662 ZNF507

2.67e-067964611IPR015880
DomainZnF_C2H2

ZNF597 TRERF1 ZMAT3 ZNF552 IKZF3 DZIP1 EEA1 GPATCH8 ZIM3 ZNF662 ZNF507

3.09e-068084611SM00355
DomainSemenogelin

SEMG1 SEMG2

5.93e-062462IPR008836
DomainSemenogelin

SEMG1 SEMG2

5.93e-062462PF05474
DomainZINC_FINGER_C2H2_2

ZNF597 TRERF1 ZNF552 IKZF3 DZIP1 EEA1 GPATCH8 ZIM3 ZNF662 ZNF507

1.50e-057754610PS50157
DomainZINC_FINGER_C2H2_1

ZNF597 TRERF1 ZNF552 IKZF3 DZIP1 EEA1 GPATCH8 ZIM3 ZNF662 ZNF507

1.53e-057774610PS00028
DomainZnf_C2H2

ZNF597 TRERF1 ZNF552 IKZF3 DZIP1 EEA1 GPATCH8 ZIM3 ZNF662 ZNF507

2.08e-058054610IPR007087
DomainG_patch

GPATCH2 AGGF1 GPATCH8

2.39e-0523463SM00443
DomainG_patch_dom

GPATCH2 AGGF1 GPATCH8

2.39e-0523463IPR000467
DomainG-patch

GPATCH2 AGGF1 GPATCH8

2.39e-0523463PF01585
DomainG_PATCH

GPATCH2 AGGF1 GPATCH8

2.39e-0523463PS50174
Domain-

ZNF597 TRERF1 ZNF552 IKZF3 DZIP1 ZIM3 ZNF662 ZNF507

2.25e-046794683.30.160.60
Domainzf-C2H2

ZNF597 TRERF1 ZNF552 IKZF3 DZIP1 ZIM3 ZNF662 ZNF507

2.58e-04693468PF00096
DomainZnf_C2H2/integrase_DNA-bd

ZNF597 TRERF1 ZNF552 IKZF3 DZIP1 ZIM3 ZNF662 ZNF507

2.61e-04694468IPR013087
DomainHATPase_c

MORC1 PMS2

8.85e-0418462SM00387
DomainHATPase_c

MORC1 PMS2

9.88e-0419462PF02518
DomainHATPase_C

MORC1 PMS2

1.21e-0321462IPR003594
Domainzf-C2H2_jaz

ZMAT3 GPATCH8

1.33e-0322462PF12171
DomainZnf_C2H2_jaz

ZMAT3 GPATCH8

1.33e-0322462IPR022755
Domain-

ANKRD30A ANKRD31 ANK3 BANK1

3.20e-032484641.25.40.20
DomainANK_REPEAT

ANKRD30A ANKRD31 ANK3 BANK1

3.43e-03253464PS50088
DomainAnkyrin_rpt-contain_dom

ANKRD30A ANKRD31 ANK3 BANK1

3.48e-03254464IPR020683
DomainANK_REP_REGION

ANKRD30A ANKRD31 ANK3 BANK1

3.48e-03254464PS50297
DomainAnkyrin_rpt

ANKRD30A ANKRD31 ANK3 BANK1

3.89e-03262464IPR002110
Pubmed

Quantification of seminal plasma motility inhibitor/semenogelin in human seminal plasma.

SEMG1 SEMG2

1.71e-06246214581514
Pubmed

Gene structure of semenogelin I and II. The predominant proteins in human semen are encoded by two homologous genes on chromosome 20.

SEMG1 SEMG2

1.71e-0624621517240
Pubmed

[Isolation and structure determination of two peptides occurring in human seminal plasma].

SEMG1 SEMG2

1.71e-0624622757795
Pubmed

Seminal vesicle secretion 2 acts as a protectant of sperm sterols and prevents ectopic sperm capacitation in mice.

SEMG1 SEMG2

1.71e-06246225395676
Pubmed

Isolation and characterization of the major gel proteins in human semen, semenogelin I and semenogelin II.

SEMG1 SEMG2

1.71e-0624628665951
Pubmed

SEMG1/2 augment energy metabolism of tumor cells.

SEMG1 SEMG2

1.71e-06246233311447
Pubmed

Ganglioside GM1 mediates decapacitation effects of SVS2 on murine spermatozoa.

SEMG1 SEMG2

1.71e-06246218753612
Pubmed

The structure of the semenogelin gene locus--nucleotide sequence of the intergenic and the flanking DNA.

SEMG1 SEMG2

1.71e-0624628654389
Pubmed

Seminal vesicle protein SVS2 is required for sperm survival in the uterus.

SEMG1 SEMG2

1.71e-06246224591616
Pubmed

Distribution and tissue expression of semenogelin I and II in man as demonstrated by in situ hybridization and immunocytochemistry.

SEMG1 SEMG2

1.71e-0624628833737
Pubmed

Human Semenogelin 1 Promotes Sperm Survival in the Mouse Female Reproductive Tract.

SEMG1 SEMG2

1.71e-06246232486486
Pubmed

Semen-coagulating protein, SVS2, in mouse seminal plasma controls sperm fertility.

SEMG1 SEMG2

1.71e-06246217123940
Pubmed

Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infection.

SEMG1 SEMG2

1.71e-06246222177559
Pubmed

Functional preservation of duplicated pair for RSVS III gene in the REST locus of rat 3q42.

SEMG1 SEMG2

1.71e-06246215582586
Pubmed

The cloning of a rapidly evolving seminal-vesicle-transcribed gene encoding the major clot-forming protein of mouse semen.

SEMG1 SEMG2

1.71e-0624628631362
Pubmed

Evolution of the hominoid semenogelin genes, the major proteins of ejaculated semen.

SEMG1 SEMG2

1.71e-06246214629036
Pubmed

Semenogelin I and II, the predominant human seminal plasma proteins, are also expressed in non-genital tissues.

SEMG1 SEMG2

1.71e-06246212200457
Pubmed

Expression of semenogelins I and II and its prognostic significance in human prostate cancer.

SEMG1 SEMG2

1.71e-06246221557275
Pubmed

Functional implications of membrane modification with semenogelins for inhibition of sperm motility in humans.

SEMG1 SEMG2

1.71e-06246219089943
Pubmed

Semenogelin I and semenogelin II, the major gel-forming proteins in human semen, are substrates for transglutaminase.

SEMG1 SEMG2

5.13e-0634629523691
Pubmed

Enzymatic action of human glandular kallikrein 2 (hK2). Substrate specificity and regulation by Zn2+ and extracellular protease inhibitors.

SEMG1 SEMG2

5.13e-06346210411640
Pubmed

Localization of the transglutaminase cross-linking site in SVS III, a novel glycoprotein secreted from mouse seminal vesicle.

SEMG1 SEMG2

5.13e-06346211723121
Pubmed

Semenogelins I and II bind zinc and regulate the activity of prostate-specific antigen.

SEMG1 SEMG2

5.13e-06346215563730
Pubmed

Deletion of a Seminal Gene Cluster Reinforces a Crucial Role of SVS2 in Male Fertility.

SEMG1 SEMG2

5.13e-06346231540031
Pubmed

Enzymatic action of prostate-specific antigen (PSA or hK3): substrate specificity and regulation by Zn(2+), a tight-binding inhibitor.

SEMG1 SEMG2

5.13e-06346211027412
Pubmed

Major role of human KLK14 in seminal clot liquefaction.

SEMG1 SEMG2

5.13e-06346218482984
Pubmed

Syp-3, a third polymorphic locus for mouse seminal vesicle proteins.

SEMG1 SEMG2

5.13e-0634626626148
Pubmed

Identification of a molecular signaling gene-gene regulatory network between GWAS susceptibility genes ADTRP and MIA3/TANGO1 for coronary artery disease.

MIA3 PIK3R3

1.03e-05446228341552
Pubmed

Epididymal protease inhibitor (EPPIN) is a protein hub for seminal vesicle-secreted protein SVS2 binding in mouse spermatozoa.

SEMG1 SEMG2

1.03e-05446232044375
Pubmed

Amidolytic activity of prostatic acid phosphatase on human semenogelins and semenogelin-derived synthetic substrates.

SEMG1 SEMG2

1.03e-05446211784334
Pubmed

Characterization of semenogelin II and its molecular interaction with prostate-specific antigen and protein C inhibitor.

SEMG1 SEMG2

1.03e-0544628665956
Pubmed

Exogenous protein kinases A and C, but not endogenous prostasome-associated protein kinase, phosphorylate semenogelins I and II from human semen.

SEMG1 SEMG2

1.03e-05446212399526
Pubmed

Human spermatozoa contain multiple targets for protein S-nitrosylation: an alternative mechanism of the modulation of sperm function by nitric oxide?

SEMG1 SEMG2

1.71e-05546217683036
Pubmed

Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).

ANKRD31 CNTLN TRAPPC9

1.77e-053846322952603
Pubmed

RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.

XRN1 CPD MIA3 TES ANK3

2.53e-0526346534702444
Pubmed

Inhibition of telomerase RNA decay rescues telomerase deficiency caused by dyskerin or PARN defects.

XRN1 TENT4B

3.58e-05746226950371
Pubmed

The major bactericidal activity of human seminal plasma is zinc-dependent and derived from fragmentation of the semenogelins.

SEMG1 SEMG2

3.58e-05746218714013
Pubmed

Somatic cell hybrids for high-density mapping of chromosome 2 breakpoints in radiation-induced myeloid leukemia cell lines from inbred mice.

SEMG1 SEMG2

4.77e-05846210708484
Pubmed

Regulation of CD8+ regulatory T cells: Interruption of the NKG2A-Qa-1 interaction allows robust suppressive activity and resolution of autoimmune disease.

KLRC4 PRF1

4.77e-05846219047627
Pubmed

Analysis of HIV-1 Gag protein interactions via biotin ligase tagging.

XRN1 SEMG1 SEMG2

5.12e-055446325631074
Pubmed

DAZ-interacting Protein 1 (Dzip1) Phosphorylation by Polo-like Kinase 1 (Plk1) Regulates the Centriolar Satellite Localization of the BBSome Protein during the Cell Cycle.

TTC8 DZIP1

7.65e-051046227979967
Pubmed

Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder.

ANK3 PCLO

9.34e-051146220351715
Pubmed

The C. elegans homolog of human panic-disorder risk gene TMEM132D orchestrates neuronal morphogenesis through the WAVE-regulatory complex.

ANKRD31 CPD PCLO

1.21e-047246333726789
Pubmed

The human cytoplasmic dynein interactome reveals novel activators of motility.

XRN1 CPD MIA3 TES CNTLN LRP1B ZNF507

1.21e-0485346728718761
Pubmed

Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway.

KLRC4 PRF1

1.32e-041346217509909
Pubmed

Degradation of histone mRNA requires oligouridylation followed by decapping and simultaneous degradation of the mRNA both 5' to 3' and 3' to 5'.

XRN1 TENT4B

1.32e-041346218172165
Pubmed

The evolution of a genetic locus encoding small serine proteinase inhibitors.

SEMG1 SEMG2

2.03e-041646215950183
Pubmed

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.

CPD DZIP1 ANK3 PCDH19 PIK3R3

2.31e-0442146536976175
Pubmed

MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm.

EEA1 LRP1B

3.54e-042146221337463
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

PTPN4 CPD PMS2 MIA3 ANK3 TEX10 PIK3R3

4.27e-04104946727880917
Pubmed

Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.

TRERF1 ZMAT3 TES TBX4 DZIP1 ZNF507

6.55e-0480846620412781
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

GPATCH2 TTC8 PTPN4 CPD MIA3 ANK3 TRAPPC9 PIK3R3

6.77e-04148946828611215
Pubmed

The transcriptome of human CD34+ hematopoietic stem-progenitor cells.

CNTLN SETD6

7.27e-043046219416867
Pubmed

Gene-smoking interactions identify several novel blood pressure loci in the Framingham Heart Study.

LRP1B TRAPPC9

8.28e-043246225189868
Pubmed

DEPDC1B coordinates de-adhesion events and cell-cycle progression at mitosis.

SEMG1 SEMG2

9.90e-043546225458010
Pubmed

Nuclear m6A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development.

SLC25A52 LRP1B

1.17e-033846229799838
Pubmed

Ptbp2 represses adult-specific splicing to regulate the generation of neuronal precursors in the embryonic brain.

DZIP1 ANK3

1.23e-033946222802532
InteractionSLC22A13 interactions

SEMG1 SEMG2

3.05e-054462int:SLC22A13
InteractionLINC02908 interactions

SEMG1 SEMG2

5.07e-055462int:LINC02908
InteractionOTOP1 interactions

SEMG1 SEMG2

5.07e-055462int:OTOP1
Cytoband1q41

GPATCH2 MIA3 AIDA

4.12e-05664631q41
CytobandEnsembl 112 genes in cytogenetic band chr1q41

GPATCH2 MIA3 AIDA

1.15e-0493463chr1q41
Cytoband5q13.3

ANKRD31 AGGF1

5.72e-04354625q13.3
GeneFamilyG-patch domain containing|Minor histocompatibility antigens

GPATCH2 AGGF1 GPATCH8

1.18e-0522373579
GeneFamilyAnkyrin repeat domain containing

ANKRD30A ANKRD31 ANK3 BANK1

1.46e-03242374403
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

PRF1 PCLO

2.46e-0336372823
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

ZNF597 ZNF552 IKZF3 ZIM3 ZNF662 ZNF507

3.12e-0371837628
ToppCellMild-Lymphoid-T-NK|Mild / Condition, Lineage, Cell class and cell subclass

TRERF1 PTPN4 IKZF3 KLRC4 PRF1

1.37e-06186465ed37a2df547661d22c1ed0b30cb1c19e489d9d0a
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PTPN4 IKZF3 ANK3 PRF1 BANK1

1.86e-06198465a3bd099ef0e606c2da690a6fcf6f79e9360c9c9f
ToppCellmild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

XRN1 PTPN4 IKZF3 KLRC4 PRF1

1.95e-06200465d8aec4904c9420b8f9d7508658ba1e36c66cdfcc
ToppCellmild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

XRN1 PTPN4 IKZF3 KLRC4 PRF1

1.95e-06200465109f673a4967ffa52270a0b4f818b3461288db44
ToppCellTCGA-Breast|World / Sample_Type by Project: Shred V9

GPATCH2 ANKRD30A ZNF552 PIK3R3

1.74e-0515046408686ba1acac5c58667bf62e2af84c691d6bbdfb
ToppCell368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|368C / Donor, Lineage, Cell class and subclass (all cells)

ZNF552 PTPN4 KLRC4 PRF1

2.13e-05158464390b9c455ed15a6804613eecfd2776949dfba146
ToppCell367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|367C / Donor, Lineage, Cell class and subclass (all cells)

PTPN4 TES KLRC4 PRF1

2.13e-05158464c08b5e12cc2975e52965e22ec987d0d45a9a68e9
ToppCelldroplet-Liver-LIVER_NPC-30m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PTPN4 IKZF3 TES PRF1

2.84e-0517046426178277bf9c7f2f06b5c0b03d4b69d78e9580c4
ToppCell390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|390C / Donor, Lineage, Cell class and subclass (all cells)

PTPN4 IKZF3 TES PRF1

2.90e-05171464d6d8ea45b443d95f64720c9bc07d324148f5b239
ToppCellNS-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

PTPN4 IKZF3 KLRC4 PRF1

2.90e-05171464adda76991d9b150bb8ccf3989b7cbbf41843cf0b
ToppCell367C-Lymphocytic-ILC-ILC-2|367C / Donor, Lineage, Cell class and subclass (all cells)

ZNF552 PTPN4 KLRC4 PRF1

3.04e-051734640451450605521fecb27a958628870d268adfb023
ToppCellNS-critical-d_0-4-Lymphoid-Treg|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

PTPN4 IKZF3 PRF1 ZNF507

3.78e-05183464f478dfa231fc1b12ead0183cc9d22077cdf43d1f
ToppCellCTRL-Lymphoid|CTRL / Disease state, Lineage and Cell class

IKZF3 PRF1 BANK1 ZNF507

3.86e-0518446426fb2c4e6cb9950c27eb15428e7e74e5abb4397d
ToppCellControl-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations)

TRERF1 IKZF3 KLRC4 PRF1

3.95e-0518546402ab64c0166c0646d1d4c6ed110ef0b75a1096d0
ToppCellControl-T_cells-NK_cells|Control / group, cell type (main and fine annotations)

TRERF1 IKZF3 KLRC4 PRF1

3.95e-05185464755c0998c729f462399f1d5e88adf4bfae31be30
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

PTPN4 IKZF3 TES PRF1

4.03e-0518646471e87c4c755ab607689cb050f5a363cb520a0f53
ToppCell10x3'2.3-week_14-16-Lymphocytic_NK-T_NK-CD56_bright_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

PTPN4 IKZF3 KLRC4 PRF1

4.03e-05186464e0eeef2b9e06324354c5a11a4c6d4c98546f32af
ToppCell5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-NK_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

IKZF3 KLRC4 PRF1 BANK1

4.03e-05186464e37e317e9770e35cb41137f51868d8b20ecd21d8
ToppCell10x5'v1-week_12-13-Lymphocytic_T-T_NK-NK_T_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

ANK3 LRP1B KLRC4 PRF1

4.03e-05186464b099cb0902e9afb11218d70407d3cab212343c6d
ToppCellSmart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

CNTLN LRP1B FCN1 PCLO

4.03e-0518646423b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCellControl-Lymphocyte-T_NK-CD8_TEM|Control / Disease, Lineage and Cell Type

PTPN4 IKZF3 KLRC4 PRF1

4.11e-051874647fdff970a9397305d0b8194c00a043cc69dcca12
ToppCell-Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

XRN1 AGGF1 ANK3 TEX10

4.20e-051884646468fa95ad0395395301115286f2d8c0df5d3882
ToppCell-Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

XRN1 AGGF1 ANK3 TEX10

4.20e-051884647a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell-Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

XRN1 AGGF1 ANK3 TEX10

4.20e-051884649cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-CD56_bright_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

PTPN4 IKZF3 KLRC4 PRF1

4.20e-051884640a2be6eac6fde669fbc58fd1b2e93e4acf17ddde
ToppCellIPF-Lymphoid-NK|IPF / Disease state, Lineage and Cell class

TRERF1 PTPN4 IKZF3 PRF1

4.29e-05189464d92e880162450f8d01e4b8784eb625275cb8e03e
ToppCell3'_v3-Lung-Lymphocytic_T_CD8-Tem/emra_CD8|Lung / Manually curated celltypes from each tissue

PTPN4 IKZF3 KLRC4 PRF1

4.29e-05189464f43bb9db7bb2d19c9849cd3ed892fe3e09e7dfe2
ToppCellCOVID-19-T_cells-CD8+_T_cells|COVID-19 / group, cell type (main and fine annotations)

TRERF1 IKZF3 KLRC4 PRF1

4.29e-051894642c018d6120f65f0b2704b483bc9da1c0984872e3
ToppCellCOPD-Lymphoid-NK|World / Disease state, Lineage and Cell class

TRERF1 PTPN4 IKZF3 PRF1

4.29e-05189464c0ac160fa7e68b92414fb1600abcac8ad1a42232
ToppCell10x3'2.3-week_12-13-Lymphocytic_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

PTPN4 IKZF3 KLRC4 PRF1

4.29e-05189464723c57f278919e8251d56b3d19411f9088319450
ToppCellNS-critical-d_0-4-Lymphoid-CTL|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

PTPN4 IKZF3 KLRC4 PRF1

4.29e-05189464fb7572fb4c7c43886d57a025decad076f32a14c4
ToppCell10x3'2.3-week_12-13-Lymphocytic_NK-T_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

PTPN4 IKZF3 KLRC4 PRF1

4.29e-05189464960374f5fb278659500a7c948c3068a95dd62eb0
ToppCellCOVID-19-T_cells-NK_cells|COVID-19 / group, cell type (main and fine annotations)

TRERF1 IKZF3 KLRC4 PRF1

4.29e-05189464b699152dfbb8cd8ed724e1e5a51838f29b681b62
ToppCell367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|367C / Donor, Lineage, Cell class and subclass (all cells)

PTPN4 IKZF3 KLRC4 PRF1

4.38e-051904644240d52a465bc3f8016834b22a35c44ba2b0a9f4
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

XRN1 PTPN4 IKZF3 PRF1

4.38e-05190464d153a0bdedcd6865e6ee19575234a78b5d859ff1
ToppCellCOVID-19-Heart-T_cell|Heart / Disease (COVID-19 only), tissue and cell type

IKZF3 LRP1B PRF1 BANK1

4.38e-05190464e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf
ToppCellBac-SEP-Lymphocyte-T_NK-gdT|Bac-SEP / Disease, Lineage and Cell Type

PTPN4 IKZF3 KLRC4 PRF1

4.38e-05190464c7c5bc50082b2243cae8eb04784d03f14a739b3b
ToppCellNS-critical-d_0-4-Lymphoid|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

PTPN4 IKZF3 KLRC4 PRF1

4.38e-0519046484f9f5ac29ff0f929a589b76efa61d4c570e76b0
ToppCellBac-SEP-Lymphocyte-T_NK-CD8_TEM|Bac-SEP / Disease, Lineage and Cell Type

PTPN4 IKZF3 KLRC4 PRF1

4.47e-0519146484e3aaed71bd35d73af475d610d1b7e71df9ce3f
ToppCellCOVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations)

TRERF1 IKZF3 ANK3 PRF1

4.47e-051914647f64add931b64b8d35836fa6bee9ebab593844d3
ToppCellIPF-Lymphoid-NK|World / Disease state, Lineage and Cell class

TRERF1 PTPN4 IKZF3 PRF1

4.47e-05191464f206159b9d5e84cf14a65bfdc008895cec5a8081
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PTPN4 IKZF3 ANK3 PRF1

4.47e-05191464b9ef6d82b86271b7e0875a399bb9aae84ef5bad3
ToppCellLeuk-UTI-Lymphocyte-T_NK-CD8_TEM|Leuk-UTI / Disease, Lineage and Cell Type

PTPN4 IKZF3 KLRC4 PRF1

4.56e-051924642787b52546eedada4aa413025b86841c351273f4
ToppCellURO-Lymphocyte-T_NK-CD8_TEM|URO / Disease, Lineage and Cell Type

PTPN4 IKZF3 KLRC4 PRF1

4.56e-0519246431b6d068f7adc6952c4cf625df851a10cb1b00c9
ToppCell10x5'v1-week_14-16-Lymphocytic_NK-T_NK-mature_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

PTPN4 IKZF3 TES PRF1

4.56e-05192464e48bbcb97c113f323ad4db96bd10d593b9206923
ToppCellNS-moderate-d_07-13-Lymphoid-CTL|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

PTPN4 IKZF3 KLRC4 PRF1

4.56e-05192464ab2c3d829f5cbf4eb386babcfdf851222a2a88e8
ToppCellcritical-Lymphoid-CTL|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

PTPN4 IKZF3 KLRC4 PRF1

4.56e-051924648c83050c1578d43ca0398ff920f30ea63f092a83
ToppCell10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-mature_NK_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

IKZF3 TENT4B KLRC4 PIK3R3

4.56e-05192464189477c44040cf0ee16c3932fa49fbd9e3acaa3c
ToppCellFetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

TRERF1 TBX4 DZIP1 CNTLN

4.56e-0519246472881b280a415e65f87a80ca1369cbb0b722a0c4
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_T_CD8|lymph-node_spleen / Manually curated celltypes from each tissue

PTPN4 IKZF3 KLRC4 PRF1

4.56e-05192464ab88ea7723f0fa3b39611981c043445f27425404
ToppCellNS-critical-d_07-13-Lymphoid-CTL|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

PTPN4 IKZF3 KLRC4 PRF1

4.56e-05192464e7e5ba94ee8fd3c04bb4c358c86d0227c563e9dc
ToppCell3'_v3-Lung-Lymphocytic_T_CD8|Lung / Manually curated celltypes from each tissue

PTPN4 IKZF3 KLRC4 PRF1

4.56e-05192464f53426b9b1a63529307751c490a5a6214e499317
ToppCellIPF-Lymphoid|IPF / Disease state, Lineage and Cell class

TRERF1 IKZF3 PRF1 BANK1

4.65e-05193464bf9d50aea909a28dd1d0933af33842d5f1ae7818
ToppCellmoderate-Lymphoid-CTL|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

PTPN4 IKZF3 KLRC4 PRF1

4.65e-051934643fce0807631811da1cff5ca9db23ff1ad36020e7
ToppCellIIH-CD8-CD8_1|IIH / Condition, Cell_class and T cell subcluster

PTPN4 IKZF3 KLRC4 PRF1

4.65e-05193464c5a4926003906d6726155f19061b73fb45d9962c
ToppCell5'-Adult-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PTPN4 IKZF3 KLRC4 PRF1

4.65e-05193464544de0988510cc57744710d7cafe07aa27a0b99d
ToppCellbackground-NK_cells|background / Sample and Cell Type and Tumor Cluster (all cells)

TRERF1 IKZF3 GPATCH8 PRF1

4.65e-05193464f8d6eff1e04926f85d265ec39fe66897fe29574d
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

PTPN4 IKZF3 KLRC4 PRF1

4.65e-05193464778fcf8448e81fe18972d97ea8a30ab036d16fe5
ToppCellIIH-CD8|IIH / Condition, Cell_class and T cell subcluster

PTPN4 IKZF3 KLRC4 PRF1

4.65e-05193464343ac8c6dc6d7c7a944a14de65f1d4ea3dfafe86
ToppCellCOVID-CD8-CD8_1|COVID / Condition, Cell_class and T cell subcluster

PTPN4 IKZF3 KLRC4 PRF1

4.65e-05193464221690901cb214c8ee186ff527c80dcc52d1fb1c
ToppCellICU-NoSEP-Lymphocyte-T_NK-CD8_TEM|ICU-NoSEP / Disease, Lineage and Cell Type

PTPN4 IKZF3 KLRC4 PRF1

4.65e-05193464848d47d3b1035f0fb36911d71d48976ee9d013fc
ToppCell10x_3'_v2v3-Non-neoplastic-Lymphoid-NK-NK-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

PTPN4 IKZF3 KLRC4 PRF1

4.75e-051944646b5be379074241973220f7ef02ef3d5d7d8428ef
ToppCellPBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

PTPN4 IKZF3 KLRC4 PRF1

4.75e-05194464ac03be73fdc32dacd4a450c0fb28617e043b8444
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

PTPN4 IKZF3 KLRC4 PRF1

4.75e-0519446464535db0420e53e4d777d2333b5051e63e8a3373
ToppCellPBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

PTPN4 IKZF3 KLRC4 PRF1

4.75e-051944647ab4418a8a12c488d74af3676bdac672628da80c
ToppCell10x_3'_v2v3-Non-neoplastic-Lymphoid-NK-NK|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

PTPN4 IKZF3 KLRC4 PRF1

4.75e-05194464f6a655e1c2be2a326b934db0a5268e4db9112a74
ToppCellMS-CD8|MS / Condition, Cell_class and T cell subcluster

PTPN4 IKZF3 KLRC4 PRF1

4.75e-051944648dfeaa213403cedecb1976bfde1bac84f0155999
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PTPN4 IKZF3 KLRC4 PRF1

4.75e-051944640fdf4d7d42d8f1f47eade2fb89ff35b188b9b51f
ToppCellPBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

PTPN4 IKZF3 KLRC4 PRF1

4.75e-05194464760761ce7d22edf9a8cec71e8ab0caa273fce3f7
ToppCellPBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

PTPN4 IKZF3 KLRC4 PRF1

4.75e-05194464e72be6dc2711c1d4f16943c8615cf9dc2e961ff3
ToppCellMultiple_Sclerosis-Lymphocyte-T_NK-CD8_TEM|Multiple_Sclerosis / Disease, Lineage and Cell Type

PTPN4 IKZF3 KLRC4 PRF1

4.75e-05194464fa53f1aab2f5923e90f090e10e3560b583441dc4
ToppCell10x_3'_v2v3-Non-neoplastic-Lymphoid-NK|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

PTPN4 IKZF3 KLRC4 PRF1

4.75e-051944644b3f400a5b7b8f999016e2daba50f65f4535b529
ToppCellCOVID-19-lung-CD4+_T_cells_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type

TRERF1 IKZF3 ANK3 PRF1

4.75e-051944642a144a1c2d537c8a59aa419206ddd96c23f0aeab
ToppCell343B-Lymphocytic-NK_cells-NK_cell_C|343B / Donor, Lineage, Cell class and subclass (all cells)

PTPN4 IKZF3 GPATCH8 PRF1

4.75e-05194464fe36cf5cf8ebd761d29ad23ee074128a12d32031
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PTPN4 IKZF3 KLRC4 PRF1

4.84e-0519546442382653e977714bff453bece26a6cd66ea2cc1f
ToppCellHealthy-CD8+_Tem|World / disease group, cell group and cell class

PTPN4 IKZF3 KLRC4 PRF1

4.84e-051954643d6f46b31c0254e9577a560364694b42964df198
ToppCell356C|World / Donor, Lineage, Cell class and subclass (all cells)

PTPN4 TES FCN1 PRF1

4.84e-05195464b19609f519188cf27859cbdc014e65fc38e24391
ToppCellCOVID-19-Lymphoid-CD8_T_cells|Lymphoid / Condition, Lineage and Cell class

TRERF1 PTPN4 IKZF3 PRF1

4.84e-05195464d4c70a462b98963e78f4e2659574bc350f8ffe1a
ToppCell10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

PTPN4 IKZF3 GPATCH8 KLRC4

4.84e-051954640a72b8446399807ace5b6c72f865bb40dbd9e92d
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PTPN4 IKZF3 BANK1 ZNF507

4.84e-05195464ed5f772c82d4dfd1c8735224446ec9feae3fb8c2
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

XRN1 MIA3 PAPSS2 PCLO

4.84e-051954647796ea9247f4c63762f0de8490fed08b9717fa23
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PTPN4 IKZF3 KLRC4 PRF1

4.94e-0519646451c750a0fb2b87e17e62b984c91fb16f676d7e76
ToppCellPBMC-Control-Lymphocyte-T/NK-Other_T-gd_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

PTPN4 IKZF3 KLRC4 PRF1

4.94e-05196464ae9bf04531b9bda819608d90736c4405a6c3df41
ToppCell10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

PTPN4 IKZF3 GPATCH8 PRF1

4.94e-05196464bd251231288c900b23d3a676ceec6ac07d228917
ToppCell10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

PTPN4 IKZF3 KLRC4 PRF1

4.94e-0519646437065ac2c89a8b5ed52af9f796e0c97909ee51a4
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

PTPN4 IKZF3 KLRC4 PRF1

4.94e-051964640f3c7fd450aaa1f866b8558692534c0ea2a34e75
ToppCellPBMC-Control-Lymphocyte-T/NK-CD8+_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

PTPN4 IKZF3 KLRC4 PRF1

4.94e-05196464c06caba0c91b8ee66f42bc43ec75eb2475f07056
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

PTPN4 IKZF3 KLRC4 PRF1

4.94e-051964644e1f8828413896ab8a4ec92a89d6789e8e37e05a
ToppCellPBMC-Control-Lymphocyte-T/NK-CD8+_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

PTPN4 IKZF3 KLRC4 PRF1

4.94e-05196464093fb240e72911dfd360aa6edf8ed2d611c78a1e
ToppCellmedial-2-Hematologic-Natural_Killer_T|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

PTPN4 IKZF3 KLRC4 PRF1

4.94e-05196464c0a3749b06c47574ab252e96688aec9eea2924de
ToppCellPBMC-Control-Lymphocyte-T/NK-Other_T-gd_T-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

PTPN4 IKZF3 KLRC4 PRF1

4.94e-05196464502834a16d5ada93af7ab9af0c3dc652086964bd
ToppCellsevere_influenza-CD8+_Tem|World / disease group, cell group and cell class (v2)

PTPN4 IKZF3 KLRC4 PRF1

4.94e-0519646440fb254abcab2e65affc5d6037e71893a031d264
ToppCell10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

PTPN4 IKZF3 TES PRF1

4.94e-05196464f424c45be7f34cbef76e1696dea10c1e3a9af2e0
ToppCellmedial-Hematologic-Natural_Killer_T|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

PTPN4 IKZF3 KLRC4 PRF1

4.94e-051964646d8430ea37bb5ade25ae6b2b1a05158e72705e66
ToppCellBL-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

PTPN4 IKZF3 KLRC4 PRF1

4.94e-05196464cfbeaabbeeb197f0cf8240a752d1f2995d59d7b7
ToppCell10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

PTPN4 IKZF3 TES PRF1

4.94e-051964649bb87d20c25df0dc8e48bcb32b57f81a3dc1c0cd
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PTPN4 ANK3 PRF1 ZNF507

4.94e-05196464c4e7133c609bcbc48c4947ea0aa1a7d9d7251b04
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PTPN4 IKZF3 GPATCH8 PRF1

4.94e-05196464a9157809122e6fc5783a291522f103bef30943e4
ToppCell10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-innate_lymphocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

PTPN4 IKZF3 GPATCH8 PRF1

4.94e-051964642849c8f06518c9523093b86167daea4c0b9eda73
ToppCell10x5'-blood-Lymphocytic_T_CD8|blood / Manually curated celltypes from each tissue

PTPN4 IKZF3 KLRC4 PRF1

4.94e-051964642bf0f36af1d0934c03999dbbff3c51ae9432386d
ComputationalNeighborhood of RAB7L1

PTPN4 TES PRF1

6.53e-0533263GNF2_RAB7L1
Diseasepack-years measurement, systolic blood pressure

LRP1B TRAPPC9

1.24e-0334452EFO_0006335, EFO_0006526
Diseaseunipolar depression, bipolar disorder

ANK3 CCDC73 PCLO

1.75e-03156453EFO_0003761, MONDO_0004985
Diseasetotal cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement

BANK1 ZNF507

2.56e-0349452EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612
Diseaseresponse to xenobiotic stimulus

ANKRD31 CNTLN TRAPPC9

2.71e-03182453GO_0009410
DiseaseChronic Lymphocytic Leukemia

IKZF3 KLRC4

3.21e-0355452C0023434
Diseasealcohol use disorder measurement

PMS2 CNTLN BANK1

4.27e-03214453EFO_0009458
Diseasecoronary artery calcification

SLC25A52 CNTLN ANK3 LRP1B

4.85e-03450454EFO_0004723

Protein segments in the cluster

PeptideGeneStartEntry
TAHNENKFYNVHFSN

BANK1

751

Q8NDB2
NLYKQNSTHTAQQAE

CNTLN

336

Q9NXG0
NLNQVSHTHENENYL

ANKRD30A

1086

Q9BXX3
HHTERLYQNAESNNQ

AGGF1

51

Q8N302
HLQKEAQAQHNNSEF

AIDA

41

Q96BJ3
DQQHDSYSQNQQSYH

TAF15

136

Q92804
NQIHYSHSQQDLESH

PTPN4

476

P29074
SHNKQEFLNVQEYNH

MORC1

411

Q86VD1
QEQHHVLYKSHENSN

ANKRD31

861

Q8N7Z5
ENQNTRNTSANHIYH

PCDH19

836

Q8TAB3
TNKQHQGKSNNQYYH

TENT4B

541

Q8NDF8
NQQKSTNVVYQAHHV

PAPSS2

11

O95340
NYSGDHQQISHIEHN

LRP1B

3906

Q9NZR2
QKHQEFDNHINSYDH

GPATCH8

146

Q9UKJ3
QSHFEQQTLYHQQVS

PCLO

3906

Q9Y6V0
HSQAANFAAQKTHQD

PRF1

151

P14222
YQSVIQGDAQHKQHQ

MS4A10

226

Q96PG2
HNNNFFSTKDQDNDV

FCN1

251

O00602
HYQQTSLVQHNDSLN

PIK3R3

431

Q92569
NQSESHKQAQENLHD

EEA1

586

Q15075
NETAHNTYHNNNKDV

CCDC73

581

Q6ZRK6
YQQQHSQVFVHHDAA

CPD

1266

O75976
HEKHDFQKDNFNNNN

ANK3

3776

Q12955
NHNNNKKDHSDSDDQ

GPATCH2

106

Q9NW75
SNHEERQNHIYQQNH

IKZF3

391

Q9UKT9
QNASSDHQGNDKTYH

KLRC4

46

O43908
NEYTQAENQNWHLKH

TES

311

Q9UGI8
SHANSQANHAQGEQA

MIA3

211

Q5JRA6
QQRETKNSHQNKGHY

SEMG1

206

P04279
KNSHQNKGHYQNVVE

SEMG1

211

P04279
NHLANHNANLEYSAN

SETD6

251

Q8TBK2
QQRETKNSHQNKGHY

SEMG2

206

Q02383
KNSHQNKGHYQNVVD

SEMG2

211

Q02383
QNHKHHDKFTNTYQA

SLC25A52

146

Q3SY17
HTEENSHFEYQKNAQ

DZIP1

221

Q86YF9
SLQHYVQNNSHDDNG

ZIM3

136

Q96PE6
VNNNNHAEAYNNLAV

TTC8

451

Q8TAM2
QVNQHHKSGFNDNSV

XRN1

1266

Q8IZH2
EHANDQQHIQVYENG

TEX10

271

Q9NXF1
QLHHEAQQSEGEQNY

PMS2

631

P54278
NDHDNDANIHTQSKA

ZNF507

176

Q8TCN5
NKLYDSGNFHQHQNE

ZNF552

126

Q9H707
SAQQAQAHYQGKNHG

ZMAT3

81

Q9HA38
QDHQNGVHNYDLHDT

TRAPPC9

1066

Q96Q05
AQHQKSHSAENTYES

ZNF597

256

Q96LX8
QHYQHENGAHSQLAE

TBX4

301

P57082
FDQNEDFDQHQKTHN

ZNF662

201

Q6ZS27
YQQSHLSQHQQREDS

TRERF1

391

Q96PN7